The Dark Side of Innate Immunity Fosters Tumor Growth and Offers New Diagnostic.
Ennio CarbonePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
So far, the tumor's immune landscape has been related mainly to the adaptive immune cell infiltrate. The possibility of using tumor-infiltrating innate immune cells as the source for prognostic markers and their role in immune checkpoint therapy have been neglected. Unraveling these aspects may lead to new immune therapy interventions.See related article by Duan et al., p. 3304.